{"id":"placebo-medication-no-counseling","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo expectation)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance with no molecular target or biological activity. Any observed clinical benefit results from psychological and neurobiological processes triggered by the expectation of treatment, including activation of endogenous pain-relief pathways, reduced anxiety, and improved symptom perception. It is commonly used as a control in clinical trials to isolate the true pharmacological effects of active drugs.","oneSentence":"Placebo has no active pharmacological mechanism; therapeutic effects arise solely from the placebo effect and patient expectations.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:16.581Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control arm (non-therapeutic use)"}]},"trialDetails":[{"nctId":"NCT05371496","phase":"PHASE2","title":"Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2022-09-06","conditions":"Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity","enrollment":81},{"nctId":"NCT04217174","phase":"NA","title":"An Avatar-based Mobile Phone Intervention to Promote Health in African American MSM","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-03-04","conditions":"Medication Adherence, Retention in Care","enrollment":315},{"nctId":"NCT07003763","phase":"NA","title":"Electroacupuncture on Treating Cancer-related Depression","status":"RECRUITING","sponsor":"Shanghai Municipal Hospital of Traditional Chinese Medicine","startDate":"2025-07-01","conditions":"Depression, Cancer","enrollment":86},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT04007393","phase":"PHASE2","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-11-21","conditions":"Adolescent Obesity","enrollment":150},{"nctId":"NCT05394779","phase":"NA","title":"DEMETRA - ADVICE-002-2022","status":"COMPLETED","sponsor":"Advice Pharma Group srl","startDate":"2022-08-23","conditions":"Obesity, Health Behavior, Life Style","enrollment":246},{"nctId":"NCT03712098","phase":"PHASE2","title":"Daily Liraglutide for Nicotine Dependence","status":"COMPLETED","sponsor":"Rebecca Ashare","startDate":"2018-11-29","conditions":"Smoking Cessation, Weight, Body","enrollment":40},{"nctId":"NCT02896712","phase":"PHASE2","title":"Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2016-11-18","conditions":"Cocaine-Related Disorders","enrollment":118},{"nctId":"NCT01944423","phase":"EARLY_PHASE1","title":"Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine","status":"COMPLETED","sponsor":"University of Texas at Austin","startDate":"2013-10","conditions":"Nicotine Addiction, Panic Attack","enrollment":53},{"nctId":"NCT00708370","phase":"PHASE4","title":"A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-08","conditions":"Dyslipidemia","enrollment":297},{"nctId":"NCT01881412","phase":"NA","title":"Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma","status":"TERMINATED","sponsor":"Rhode Island Hospital","startDate":"2012-08","conditions":"Asthma","enrollment":118},{"nctId":"NCT02771925","phase":"PHASE4","title":"Treatment for Alcohol Dependence With Gabapentin","status":"TERMINATED","sponsor":"Dayanand Medical College and Hospital","startDate":"2016-06","conditions":"Alcohol Dependence","enrollment":25},{"nctId":"NCT00448669","phase":"PHASE2, PHASE3","title":"Botswana TDF/FTC Oral HIV Prophylaxis Trial","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2007-03","conditions":"HIV Infections","enrollment":1219},{"nctId":"NCT00780702","phase":"PHASE1","title":"Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2008-05-08","conditions":"Cocaine Dependence, Cocaine-Related Disorders, Opioid-Related Disorders","enrollment":41},{"nctId":"NCT02765581","phase":"NA","title":"Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura","status":"COMPLETED","sponsor":"Wei Wang","startDate":"2016-05-01","conditions":"Migraine Without Aura","enrollment":150},{"nctId":"NCT00086411","phase":"PHASE2","title":"Comparing Smoking Treatment Programs for Lighter Smokers - 1","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2003-09","conditions":"Tobacco Use Disorder","enrollment":260},{"nctId":"NCT00756275","phase":"NA","title":"Varenicline and Motivational Advice for Smokers With Substance Use Disorders","status":"COMPLETED","sponsor":"Brown University","startDate":"2009-01","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":158},{"nctId":"NCT03109834","phase":"PHASE3","title":"Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women","status":"COMPLETED","sponsor":"Bonn Education Association for Dietetics r.A., Cologne, Germany","startDate":"2004-03-25","conditions":"Overweight and Obesity, Dyslipoproteinemia","enrollment":105},{"nctId":"NCT00087880","phase":"PHASE2","title":"Maintaining Abstinence in Chronic Cigarette Smokers - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-12","conditions":"Tobacco Use Disorder","enrollment":407},{"nctId":"NCT01621009","phase":"PHASE4","title":"Bupropion SR Plus Counseling for Smoking Cessation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-01","conditions":"Tobacco Dependence, Smoking","enrollment":463},{"nctId":"NCT02540382","phase":"NA","title":"Comparison of Covered and Bare Stent in TIPS","status":"COMPLETED","sponsor":"Beijing Shijitan Hospital, Capital Medical University","startDate":"2006-01","conditions":"Cirrhosis","enrollment":258},{"nctId":"NCT01980550","phase":"PHASE4","title":"Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy","status":"COMPLETED","sponsor":"National Institute on Drug Dependence, China","startDate":"2004-03","conditions":"Nicotine Dependence","enrollment":250},{"nctId":"NCT01427218","phase":"NA","title":"Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease","status":"UNKNOWN","sponsor":"Middle Tennessee Research Institute","startDate":"2010-11","conditions":"Coronary Heart Disease, Myocardial Infarction","enrollment":170}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo medication, No counseling","genericName":"Placebo medication, No counseling","companyName":"University of Wisconsin, Madison","companyId":"university-of-wisconsin-madison","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo has no active pharmacological mechanism; therapeutic effects arise solely from the placebo effect and patient expectations. Used for Clinical trial control arm (non-therapeutic use).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}